Equity
Weighted Average Exercise Price of Outstanding Options
Merck & Co. Weighted Average Exercise Price of Outstanding Options increased by 2.2% to $87.95 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.2%, from $86.04 to $87.95. Over 5 years (FY 2020 to FY 2025), Weighted Average Exercise Price of Outstanding Options shows an upward trend with a 6.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025Feb 24, 2026
How to read this metric
If the market price is significantly higher than the exercise price, it indicates strong employee incentive alignment but potential future dilution.
Detailed definition
This metric calculates the average price at which holders of outstanding stock options can purchase company shares. It p...
Peer comparison
Standard metric for analyzing the cost and impact of equity incentive plans.
Metric ID:
weighted_avg_exercise_price_options_outstandingHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $65.27 | $70.55 | $77.54 | $86.04 | $87.95 |
| QoQ Change | — | +8.1% | +9.9% | +11.0% | +2.2% |
| YoY Change | — | +8.1% | +9.9% | +11.0% | +2.2% |
Range$65.27 – $87.95
CAGR+34.7%
Avg YoY Growth+7.8%
Median YoY Growth+9.0%
Current Streak4+ quarters growth
Weighted Average Exercise Price of Outstanding Options at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s weighted average exercise price of outstanding options?
- Merck & Co. (MRK) reported weighted average exercise price of outstanding options of $87.95 in Q4 2025.
- How has Merck & Co.'s weighted average exercise price of outstanding options changed year-over-year?
- Merck & Co.'s weighted average exercise price of outstanding options increased by 2.2% year-over-year, from $86.04 to $87.95.
- What is the long-term trend for Merck & Co.'s weighted average exercise price of outstanding options?
- Over 5 years (2020 to 2025), Merck & Co.'s weighted average exercise price of outstanding options has grown at a 6.7% compound annual growth rate (CAGR), from $63.64 to $87.95.
- What does weighted average exercise price of outstanding options mean?
- The average price at which employees can buy company stock through their existing options.